Literature DB >> 24881949

Reply: β2-agonists and acute respiratory distress syndrome.

G R Scott Budinger1, Gökhan M Mutlu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24881949      PMCID： PMC4098089          DOI： 10.1164/rccm.201404-0644LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

1.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

2.  Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.

Authors:  Michael A Matthay; Roy G Brower; Shannon Carson; Ivor S Douglas; Mark Eisner; Duncan Hite; Steven Holets; Richard H Kallet; Kathleen D Liu; Neil MacIntyre; Marc Moss; David Schoenfeld; Jay Steingrub; B Taylor Thompson
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

Review 3.  Neural control of renal function.

Authors:  G F DiBona; U C Kopp
Journal:  Physiol Rev       Date:  1997-01       Impact factor: 37.312

4.  Prone positioning in severe acute respiratory distress syndrome.

Authors:  Claude Guérin; Jean Reignier; Jean-Christophe Richard; Pascal Beuret; Arnaud Gacouin; Thierry Boulain; Emmanuelle Mercier; Michel Badet; Alain Mercat; Olivier Baudin; Marc Clavel; Delphine Chatellier; Samir Jaber; Sylvène Rosselli; Jordi Mancebo; Michel Sirodot; Gilles Hilbert; Christian Bengler; Jack Richecoeur; Marc Gainnier; Frédérique Bayle; Gael Bourdin; Véronique Leray; Raphaele Girard; Loredana Baboi; Louis Ayzac
Journal:  N Engl J Med       Date:  2013-05-20       Impact factor: 91.245

5.  β2-agonists and acute respiratory distress syndrome.

Authors:  G R Scott Budinger; Gökhan M Mutlu
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

6.  The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial.

Authors:  Gavin D Perkins; Daniel F McAuley; David R Thickett; Fang Gao
Journal:  Am J Respir Crit Care Med       Date:  2005-10-27       Impact factor: 21.405

7.  β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis.

Authors:  Sergio E Chiarella; Saul Soberanes; Daniela Urich; Luisa Morales-Nebreda; Recep Nigdelioglu; David Green; James B Young; Angel Gonzalez; Carmen Rosario; Alexander V Misharin; Andrew J Ghio; Richard G Wunderink; Helen K Donnelly; Kathryn A Radigan; Harris Perlman; Navdeep S Chandel; G R Scott Budinger; Gökhan M Mutlu
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

Review 8.  Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis.

Authors:  Matthias Briel; Maureen Meade; Alain Mercat; Roy G Brower; Daniel Talmor; Stephen D Walter; Arthur S Slutsky; Eleanor Pullenayegum; Qi Zhou; Deborah Cook; Laurent Brochard; Jean-Christophe M Richard; Francois Lamontagne; Neera Bhatnagar; Thomas E Stewart; Gordon Guyatt
Journal:  JAMA       Date:  2010-03-03       Impact factor: 56.272

9.  The beta agonist lung injury trial prevention. A randomized controlled trial.

Authors:  Gavin D Perkins; Simon Gates; Daniel Park; Fang Gao; Chris Knox; Ben Holloway; Daniel F McAuley; James Ryan; Joseph Marzouk; Matthew W Cooke; Sarah E Lamb; David R Thickett
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

10.  Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.

Authors:  Fang Gao Smith; Gavin D Perkins; Simon Gates; Duncan Young; Daniel F McAuley; William Tunnicliffe; Zahid Khan; Sarah E Lamb
Journal:  Lancet       Date:  2011-12-11       Impact factor: 79.321
  10 in total
  1 in total

Review 1.  Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.

Authors:  Hayder M Al-Kuraishy; Ali Ismail Al-Gareeb; Gomaa Mostafa-Hedeab; Keneth Iceland Kasozi; Gerald Zirintunda; Akhmed Aslam; Mamdouh Allahyani; Susan Christina Welburn; Gaber El-Saber Batiha
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.